1,158 results match your criteria Archives of Cardiovascular Diseases[Journal]


Design and preliminary results of FRENSHOCK 2016: A prospective nationwide multicentre registry on cardiogenic shock.

Arch Cardiovasc Dis 2019 Apr 11. Epub 2019 Apr 11.

Inserm, CNRS, PhyMedExp, cardiology department, université de Montpellier, CHU de Montpellier, 34295 Montpellier, France.

Background: Most data on the epidemiology of cardiogenic shock (CS) have come from patients with acute myocardial infarction admitted to intensive cardiac care units (ICCUs). However, CS can have other aetiologies, and could be managed in intensive care units (ICUs), especially the most severe forms of CS.

Aim: To gather data on the characteristics, management and outcomes of patients hospitalized in ICCUs and ICUs for CS, whatever the aetiology, in France in 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.02.001DOI Listing

Response to the letter about the article "Prognosis of severe congenital heart diseases: Do we overestimate the impact of prenatal diagnosis?"

Arch Cardiovasc Dis 2019 Apr 11. Epub 2019 Apr 11.

Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, University Hospital, Montpellier, France; PhyMedExp, CNRS, INSERM, University of Montpellier, Montpellier, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136193007
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2019.04.001DOI Listing
April 2019
1 Read

Letter in response to the article entitled "Prognosis of severe congenital heart diseases: Do we overestimate the impact of prenatal diagnosis?" by Vincenti et al.

Arch Cardiovasc Dis 2019 Apr 9. Epub 2019 Apr 9.

Paediatric and congenital cardiology unit, Bordeaux university hospital, 33604 Pessac, France; IHU Lyric, electrophysiology and heart modelling institute, Fondation Bordeaux université, 33600 Pessac, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.03.002DOI Listing

Four-dimensional flow cardiovascular magnetic resonance: Towards accurate flow quantification?

Authors:
Jérôme Garot

Arch Cardiovasc Dis 2019 Apr 21;112(4):223-225. Epub 2019 Mar 21.

IRM Cardiovasculaire, Institut Cardiovasculaire Paris Sud (ICPS), Hôpital Privé Jacques-Cartier, Ramsay-Générale de Santé, 6, avenue du Noyer-Lambert, 91300 Massy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.03.001DOI Listing

Coronary artery disease in black African patients with diabetes: Insights from an Ivorian cardiac catheterization centre.

Arch Cardiovasc Dis 2019 Mar 18. Epub 2019 Mar 18.

Abidjan Heart Institute, 01 BP V206 Abidjan, Côte d'Ivoire.

Background: Coronary angiography data are scarce for black patients with diabetes.

Aim: To assess coronary angiography findings in patients with diabetes at the Abidjan Heart Institute.

Methods: This observational cross-sectional survey was conducted between 1 April 2010 and 31 December 2014. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136193005
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2019.01.003DOI Listing
March 2019
3 Reads

Fabry disease in cardiology practice: Literature review and expert point of view.

Arch Cardiovasc Dis 2019 Apr 28;112(4):278-287. Epub 2019 Feb 28.

French Referral Centre for Fabry Disease, Division of Medical Genetics, hôpital Raymond-Poincare, AP-HP, 92380 Garches, France; Inserm U1179, University of Versailles, 78180 Montigny, France.

Fabry disease is an X-linked progressive multisystemic genetic sphingolipidosis caused by deficient activity of lysosomal α-galactosidase A. Men aged>30 years and women aged>40 years most often present with unexplained left ventricular hypertrophy, usually concentric and non-obstructive, but sometimes mimicking sarcomeric hypertrophic cardiomyopathy, particularly when isolated, as in the cardiac or late-onset variant of the disease. In hypertrophic cardiomyopathy cohorts, up to 1% of patients have been diagnosed with Fabry disease. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136193003
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2019.01.002DOI Listing
April 2019
3 Reads

Transcatheter pulmonary valvuloplasty in neonates with pulmonary atresia and intact ventricular septum.

Arch Cardiovasc Dis 2019 Feb 20. Epub 2019 Feb 20.

Pôle des cardiopathies congénitales de l'enfant et de l'adulte, centre de référence malformations cardiaques congénitales complexes (M3C), hôpital Marie-Lannelongue, université Paris-Sud, université Paris-Saclay, 133, avenue de la Résistance, 92350 Le Plessis-Robinson, France.

Background: Transcatheter pulmonary valvuloplasty in neonates with pulmonary atresia and intact ventricular septum (PA-IVS) or duct-dependent pulmonary valve stenosis (DD-PVS) has become a reasonable alternative to surgical right ventricle decompression.

Aim: To investigate mid-term outcomes following pulmonary valvuloplasty.

Methods: Sixty-five neonates with PA-IVS (n=29) or DD-PVS (n=36) (median age 4 days; mean weight 3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.015DOI Listing
February 2019
5 Reads

Closure of patent foramen ovale and "cryptogenic" stroke: What's new, what's next?

Authors:
Jean-Louis Mas

Arch Cardiovasc Dis 2019 Mar 18;112(3):145-149. Epub 2019 Feb 18.

Inserm 894, Department of Neurology, DHU NeuroVasc Sorbonne Paris-Cité, Paris Descartes University, Hôpital Sainte-Anne, 75674 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.01.001DOI Listing
March 2019
1 Read

Which high-sensitivity troponin variable best characterizes infarct size and microvascular obstruction?

Arch Cardiovasc Dis 2019 Feb 15. Epub 2019 Feb 15.

Cardiology division, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34090 Montpellier, France; Inserm U1046, PhyMedExp, University of Montpellier, CNRS UMR 9214, 34090 Montpellier, France.

Background: The link between hs-Tn and infarct size has already been proved in several articles. However few is known about the kinetic of the troponin and its link to the infarct characteristics, likewise MVO. Our primary objective was to study which hs-Tn characterizes the best infarction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.12.001DOI Listing
February 2019
1 Read

Ten-year follow-up of unreplaced Valsalva sinuses after aortic valve replacement in bicuspid aortic valve disease.

Arch Cardiovasc Dis 2019 Feb 13. Epub 2019 Feb 13.

Department of Cardiovascular Surgery, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France; School of Medicine, Paris Descartes University, Sorbonne Paris Cité, 75006 Paris, France.

Background: Aortopathy is common in patients with bicuspid aortic valve (BAV).

Aim: To evaluate the fate of unreplaced Valsalva sinuses in patients with BAV, 10 years after aortic valve replacement (AVR) with or without replacement of the ascending aorta (RAA).

Methods: We retrospectively reviewed all surgical patients with BAV who were operated on between January 2005 and December 2007. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.014DOI Listing
February 2019
1 Read

Prognosis of severe congenital heart diseases: Do we overestimate the impact of prenatal diagnosis?

Arch Cardiovasc Dis 2019 Apr 2;112(4):261-269. Epub 2019 Feb 2.

Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, University Hospital, 34295 Montpellier, France; Inserm, PhyMedExp, CNRS, University of Montpellier, 34295 Montpellier, France; Paediatric Cardiology and Rehabilitation Unit, Saint-Pierre Institute, 34250 Palavas-Les-Flots, France. Electronic address:

Background: Prenatal diagnosis of congenital heart disease (CHD) is controversial because of unclear benefits in terms of morbidity and mortality, and issues with healthcare costs and organization.

Aim: To compare, in children with severe CHD, 1-year morbidity and mortality between prenatal and postnatal diagnosis groups.

Methods: All pregnancies and children aged<1 year with a diagnosis of severe CHD were collected over a 5-year period from our database. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.013DOI Listing
April 2019
1 Read

Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.

Arch Cardiovasc Dis 2019 Mar 22;112(3):171-179. Epub 2019 Jan 22.

Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK; School of Medicine, Belgrade University, Belgrade 11000, Serbia; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg DK-9000, Denmark. Electronic address:

Background: Female sex has been linked with worse prognosis in patients with atrial fibrillation (AF). Clinical risk stratification of women with AF may help decision-making before catheter ablation (CA).

Aim: To evaluate arrhythmia outcomes and the predictive value of clinical scores for arrhythmia recurrence in a large cohort of Chinese patients with AF undergoing CA. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136193000
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.10.006DOI Listing
March 2019
13 Reads

Epicardial fat thickness predicts atrial fibrillation recurrence after a first pulmonary vein isolation procedure using a second-generation cryoballoon.

Arch Cardiovasc Dis 2019 Jan 19. Epub 2019 Jan 19.

Cardiology department, CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France.

Background: Atrial fibrillation is the most common arrhythmia in adults. A relationship between epicardial adipose tissue and atrial fibrillation has recently been reported.

Aim: To evaluate the impact of epicardial fat thickness on the outcome of patients who underwent a first pulmonary vein isolation procedure using a second-generation cryoballoon. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.011DOI Listing
January 2019

Baroreflex sensitivity assessed with the sequence method is associated with ventricular arrhythmias in patients implanted with a defibrillator for the primary prevention of sudden cardiac death.

Arch Cardiovasc Dis 2019 Apr 19;112(4):270-277. Epub 2019 Jan 19.

CHU Poitiers, CIC 1402, 86021 Poitiers, France; Faculté de médecine et pharmacie, université Poitiers, 86021 Poitiers, France.

Background: Left ventricular ejection fraction lacks accuracy in predicting sudden cardiac death, resulting in unnecessary implantation of cardioverter defibrillators for the primary prevention of sudden cardiac death. Baroreflex sensitivity could help to stratify patients at risk of ventricular arrhythmia.

Aim: To assess the association between cardiac baroreflex sensitivity and ventricular arrhythmias in patients implanted with an implantable cardioverter defibrillator for the primary prevention of sudden cardiac death after myocardial infarction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.009DOI Listing
April 2019
3 Reads

Evolution of chronic kidney disease after surgical aortic valve replacement or transcatheter aortic valve implantation.

Arch Cardiovasc Dis 2019 Mar 14;112(3):162-170. Epub 2019 Jan 14.

Service de cardiologie, institut Pascal, université Clermont-Auvergne, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France.

Background: Immediate improvement in kidney function has been reported after surgical aortic valve replacement or transcatheter aortic valve implantation. Long-term data, however, are not available.

Aim: To assess the evolution of kidney function in chronic kidney disease stage 3b-5, 1 year after surgical aortic valve replacement or transcatheter aortic valve implantation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.10.003DOI Listing
March 2019
4 Reads

Factors associated with delay in transfer of patients with ST-segment elevation myocardial infarction from first medical contact to catheterization laboratory: Lessons from CRAC, a French prospective multicentre registry.

Arch Cardiovasc Dis 2019 Jan 14;112(1):3-11. Epub 2019 Jan 14.

Unité régionale d'épidémiologie hospitalière (UREH), 37044 Tours, France.

Background: It is critical to minimize the time between the first medical contact and primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Aims: To identify factors associated with a delay of>120min between first medical contact and primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Methods: Data were analysed from a regional French registry of patients undergoing coronary angioplasty for ST-segment elevation myocardial infarction<24h after symptom onset. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.04.008DOI Listing
January 2019
2 Reads

Editorial.

Arch Cardiovasc Dis 2019 Jan 14;112(1):1-2. Epub 2019 Jan 14.

Service de cardiologie, hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.08.003DOI Listing
January 2019
2 Reads

How should we implement the recommendations of the Acute Cardiovascular Care Association in intensive cardiac care units in France?

Arch Cardiovasc Dis 2019 Feb 11;112(2):79-81. Epub 2019 Jan 11.

Cardiology Department, Inserm U942, Lariboisière Hospital, AP-HP, Paris Diderot University, 75010 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.10.005DOI Listing
February 2019
1 Read

Cardiovascular research in France: Evolution of scientific activities and production over the last decade.

Arch Cardiovasc Dis 2019 Apr 11;112(4):241-252. Epub 2019 Jan 11.

U1099, LTSI-Inserm, université de Rennes, 35043 Rennes, France.

Background: Cardiovascular disease (CVD) is a major cause of death worldwide, and fruitful research is needed for future advances in this field.

Aims: To analyse the scientific production and vitality of French cardiovascular clinical research, and its evolution over the last decade.

Methods: We first used Lab Times online data obtained through the Web of Science (Thomson-Reuters, Toronto, ON, Canada), then the PubMed database (National Center for Biotechnology Information [NCBI], Bethesda, MD, USA), for studies published between 2005 and 2015 in the multidisciplinary and cardiology journals with the highest impact factors. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183019
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.11.003DOI Listing
April 2019
7 Reads

Medication reconciliation: Predictors of risk of unintentional medication discrepancies in the cardiology department.

Arch Cardiovasc Dis 2019 Feb 11;112(2):104-112. Epub 2019 Jan 11.

Department of Pharmacy, Saint-Antoine Hospital, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.

Background: Medication reconciliation is a powerful formal process to decrease medication errors, but it has proved to be complex and time consuming.

Aims: To describe the frequency and types of medication discrepancies (between previous treatment and medication order at admission), and to identify predictors of unintentional medication discrepancies (UMDs).

Methods: This interventional study was carried out in the cardiology department of a French teaching hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.09.004DOI Listing
February 2019
3 Reads

Safeguarding continuing cardiovascular research excellence and quality publications in France: A working document from the French Society of Cardiology.

Arch Cardiovasc Dis 2019 Apr 10;112(4):234-240. Epub 2019 Jan 10.

Department of Cardiology, CHU de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France. Electronic address:

Background: France has a long history of successful cardiovascular research and scientific innovations, but its continued success cannot be taken for granted.

Aims: To identify current obstacles to cardiovascular research in France and to crystallize the analysis into recommendations for maintained and enhanced research excellence in the future.

Methods: The French Society of Cardiology set up seven Working Groups, each comprising four to eight cardiologists, covering a spectrum of research institutes, hospitals, specialties, ages and research experience. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.002DOI Listing
April 2019
2 Reads

Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.

Arch Cardiovasc Dis 2019 Mar 9;112(3):180-186. Epub 2019 Jan 9.

Sorbonne université , ACTION Study group , Institut de Cardiologie (APHP), INSERM UMRS 1166 , hôpital Pitié-Salpêtrière, 75013 Paris, France. Electronic address:

Background: Two biomarkers of early acute kidney injury-plasmatic neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C-are not used in routine clinical practice in patients with ST-segment elevation myocardial infarction (STEMI) treated by percutaneous coronary intervention (PCI) because of a lack of supporting data.

Aims: To evaluate the predictive value of NGAL and cystatin C regarding the incidence of contrast-induced acute kidney injury (CI-AKI) and clinical outcomes after STEMI in patients treated by primary PCI.

Methods: Plasmatic NGAL and cystatin C were measured on admission, before any contrast exposure, in 701 unselected patients with STEMI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.006DOI Listing
March 2019
3 Reads

Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry.

Arch Cardiovasc Dis 2019 Feb 7;112(2):113-123. Epub 2019 Jan 7.

Service de cardiologie et maladies vasculaires, CIC-IT 804, hôpital Pontchaillou, CHU de Rennes, 35033 Rennes, France; Inserm U1099, laboratoire de traitement du signal et de l'image, université de Rennes 1, 35000 Rennes, France.

Background: Several randomized studies have shown that bioresorbable vascular scaffold (BVS) technology is associated with an increased risk of stent thrombosis.

Aim: This study aimed to assess the rates of adverse outcomes at 1 year in patients treated with the Absorb BVS (Abbott Vascular, Santa Clara, CA, USA), using data from a large nationwide prospective multicentre registry (FRANCE ABSORB).

Methods: All patients receiving the Absorb BVS in France were included prospectively in the study. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183019
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.09.007DOI Listing
February 2019
18 Reads

Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR).

Arch Cardiovasc Dis 2019 Mar 6;112(3):199-216. Epub 2019 Jan 6.

Service d'angiologie et d'hémostase, département de spécialités de médecine, hôpitaux universitaires de Genève, 1205 Genève, Switzerland; Geneva Platelet Group, faculté de médecine, université de Genève, 1205 Genève, Switzerland.

The French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Haemostasis and Thrombosis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR), drafted up-to-date proposals on the management of antiplatelet therapy for non-elective invasive procedures or bleeding complications. The proposals were discussed and validated by a vote; all proposals could be assigned with a high strength. Management of oral antiplatelet agents in emergency settings requires knowledge of their pharmacokinetic and pharmacodynamic parameters, evaluation of the degree of alteration of haemostatic competence and the associated bleeding risk. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.10.004DOI Listing
March 2019
3 Reads

ExtraCorporeal life support for Cardiac ARrest in patients with post cardiac arrest syndrome: The ECCAR study.

Arch Cardiovasc Dis 2019 Apr 3;112(4):253-260. Epub 2019 Jan 3.

Medical and Toxicologic Intensive Care Unit, Lariboisière University Hospital, AP-HP, 75010 Paris, France; Paris VII University, 75013 Paris, France.

Background: Post cardiac arrest shock (PCAS) occurring after resuscitated cardiac arrest (CA) is a main cause of early death. Extracorporeal life support (ECLS) could be useful pending recovery from myocardial failure.

Aim: To describe our PCAS population, and the factors associated with initiation of ECLS. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183019
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.11.005DOI Listing
April 2019
20 Reads

Accuracy of claim data in the identification and classification of adults with congenital heart diseases in electronic medical records.

Arch Cardiovasc Dis 2019 Jan 3;112(1):31-43. Epub 2019 Jan 3.

Inserm-UMRS 1138, Team 22, Cordeliers Research Centre, Paris Descartes University, 15, rue de l'École de Médecine, 75006 Paris, France; Department of Medical Informatics and Public Health, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.

Background: The content of electronic medical records (EMRs) encompasses both structured data, such as billing codes, and unstructured data, including free-text reports. Epidemiological and clinical research into adult congenital heart disease (ACHD) increasingly relies on administrative claim data using the International Classification of Diseases (9th revision) (ICD-9). In France, administrative databases use ICD-10, the reliability of which is largely unknown in this context. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.07.002DOI Listing
January 2019
8 Reads

Incidence of major adverse cardiac events in men wishing to continue competitive sport following percutaneous coronary intervention.

Arch Cardiovasc Dis 2019 Apr 3;112(4):226-233. Epub 2019 Jan 3.

CIC-IT, Inserm 1414, 35033 Rennes, France; Service de Médecine du Sport, CHU Rennes, 35033 Rennes, France; Laboratoire de Traitement du Signal et de l'Image (LTSI), Inserm UMR 1099, 35043 Rennes, France. Electronic address:

Background: The new North American guidelines for participation in competitive sport in patients with coronary artery disease (CAD) are less restrictive than previous guidelines.

Aim: To evaluate the incidence of major adverse cardiac events (MACE) in men with CAD who practise intensive physical activity after a stenting procedure. MACE included in-stent restenosis (SR), stent thrombosis (ST), new coronary stenosis (NCS), myocardial infarction, heart failure, cardiac arrest or cardiac death. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183020
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.11.008DOI Listing
April 2019
17 Reads

Lessons from MITRA-FR and COAPT studies: Can we hope for an indication for severe functional mitral regurgitation in systolic heart failure?

Authors:
Yves Juillière

Arch Cardiovasc Dis 2018 Dec 31. Epub 2018 Dec 31.

Department of Cardiology, Institut Lorrain du Cœur et des Vaisseaux, CHU Nancy-Brabois, Allée du Morvan, 54500 Vandoeuvre-les-Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183019
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.11.004DOI Listing
December 2018
16 Reads

Hypercholesterolaemia and coronary artery disease: A silent killer with several faces.

Authors:
Jean Ferrières

Arch Cardiovasc Dis 2019 Feb 31;112(2):75-78. Epub 2018 Dec 31.

Department of Cardiology and Department of Epidemiology, Health Economics and Public Health, UMR Inserm 1027, Toulouse-Rangueil University Hospital, Toulouse University School of Medicine, 31059 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.11.007DOI Listing
February 2019
3 Reads

Usefulness of head-up tilt test combined with video electroencephalogram to investigate recurrent unexplained atypical transient loss of consciousness.

Arch Cardiovasc Dis 2019 Feb 29;112(2):82-94. Epub 2018 Dec 29.

Service de neurophysiologie clinique, hôpital Roger-Salengro, CHRU de Lille, avenue du Professeur-Emile-Laine, 59037 Lille, France.

Background: Convulsive syncope and epileptic seizure share many similar clinical features. Early diagnosis is critical for choosing the appropriate management strategy.

Aim: Our aim was to evaluate the diagnostic yield of an innovative diagnostic strategy - combined head-up tilt test (HUT)/video electroencephalogram (EEG) monitoring - in patients with unexplained seizure-like transient loss of consciousness (T-LOC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.08.004DOI Listing
February 2019
3 Reads

Long-term results of surgical treatment of secondary severe mitral regurgitation in patients with end-stage heart failure: Advantage of prosthesis insertion.

Arch Cardiovasc Dis 2019 Feb 29;112(2):95-103. Epub 2018 Dec 29.

Department of Cardiology, La Timone Hospital, AP-HM, 13005 Marseille, France. Electronic address:

Background: Surgical treatment of secondary mitral regurgitation (SMR) is controversial.

Aim: To analyse outcome after undersizing annuloplasty (UA) and mitral valve replacement (MVR).

Methods: Consecutive patients operated on for severe SMR, with left ventricular ejection fraction (LVEF)<40% and refractory CHF, were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.09.006DOI Listing
February 2019
8 Reads

Common p2y polymorphisms are associated with plasma inhibitory factor 1 and lipoprotein(a) concentrations, heart rate and body fat mass: The GENES study.

Arch Cardiovasc Dis 2019 Feb 29;112(2):124-134. Epub 2018 Dec 29.

Inserm, UMR 1048, Institute of Metabolic and Cardiovascular Diseases, 31432 Toulouse, France; Paul Sabatier University, University of Toulouse, 31330 Toulouse, France; Service de biochimie, Pôle Biologie, Hôpital Purpan, CHU de Toulouse, 31300 Toulouse, France.

Background: The P2Y purinergic receptor regulates hepatic high-density lipoprotein uptake and biliary sterol secretion; it acts downstream of the membrane ecto-F1-adenosine triphosphatase, which generates extracellular adenosine diphosphate that selectively activates P2Y, resulting in high-density lipoprotein endocytosis. Previous studies have shown that the serum concentration of the F1-adenosine triphosphatase inhibitor inhibitory factor 1 is negatively associated with cardiovascular risk.

Aim: To evaluate whether p2y genetic variants affect cardiovascular risk. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.09.003DOI Listing
February 2019
1 Read

Disparities in death rates in women with peripartum cardiomyopathy between advanced and developing countries: A systematic review and meta-analysis.

Arch Cardiovasc Dis 2019 Mar 26;112(3):187-198. Epub 2018 Dec 26.

Division of Cardiovascular Medicine, Department of Medicine, Stony Brook University Medical Center, State University of New York, Stony Brook, Nichols road, 11794 NY, United States of America. Electronic address:

There is limited information about differences in maternal deaths from peripartum cardiomyopathy (PPCM) between advanced and developing countries. To review the literature to define the global prevalence of death from PPCM, and to determine the differences in PPCM mortality rates and risk factors between advanced and developing countries. Studies in the English language reporting mortality data on patients with PPCM were included from searches of MEDLINE, Embase, CINAHL, the Cochrane Library, the Web of Science Core Collection and Scopus from 01 January 2000 to 11 May 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.10.002DOI Listing
March 2019
6 Reads

Automated external defibrillator use in out-of-hospital cardiac arrest: Current limitations and solutions.

Arch Cardiovasc Dis 2019 Mar 26;112(3):217-222. Epub 2018 Dec 26.

Paris Cardiovascular Research Centre (Inserm U970), 75015 Paris, France; Sudden Death Expertise Centre, 75015 Paris, France; Cardiology Department, Georges Pompidou European Hospital, 75015 Paris, France; Paris Descartes University, 75006 Paris, France. Electronic address:

Out-of-hospital sudden cardiac arrest (OHCA) is a major public health issue, with a survival rate at hospital discharge that remains below 10% in most cities, despite huge investments in this domain. Early basic life support (BLS) and early defibrillation using automated external defibrillators (AEDs) stand as key elements for improving OHCA survival rate. Nevertheless, the use of AEDs in OHCA remains low, for a variety of reasons, including the number, accessibility and ease of locating AEDs, as well as bystanders' awareness of BLS manœuvres and of the need to use AEDs. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183018
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.11.001DOI Listing
March 2019
11 Reads

The best DEFENSE for high-risk patent foramen ovale: An updated meta-analysis of six randomized trials.

Arch Cardiovasc Dis 2019 Mar 26;112(3):150-152. Epub 2018 Dec 26.

Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, 10461 NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.06.001DOI Listing
March 2019
2 Reads

Occurrence of significant long PR intervals in patients implanted for sinus node dysfunction and monitored with SafeR™: The PRECISE study.

Arch Cardiovasc Dis 2019 Mar 26;112(3):153-161. Epub 2018 Dec 26.

Henri Mondor hospital, 94101 Créteil, France.

Background: Long PR intervals may increase cardiovascular complications, including atrial fibrillation. In pacemakers, the SafeR™ mode monitors PR intervals, switching from AAI to DDD when criteria for atrioventricular block are met.

Aims: The PRECISE study evaluated the incidence and predictors of long PR intervals and their association with incident atrial fibrillation after 1 year in patients implanted for sinus node dysfunction and free from significant conduction disorders at baseline. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.09.005DOI Listing
March 2019
4 Reads

Contractibility sensor signal evolution predicts cardiovascular events in patients with cardiac resynchronization therapy.

Arch Cardiovasc Dis 2019 Jan 24;112(1):22-30. Epub 2018 Dec 24.

Service de cardiologie, CHU de Poitiers, 86021 Poitiers, France.

Background: While a multicentre trial has demonstrated that the SonR™ contractibility sensor is as effective as echocardiography-guided optimization at improving response to cardiac resynchronization therapy, an association between SonR™ values and clinical endpoints has not been established.

Aims: The primary objective was to assess the predictive value of SonR™ signal evolution regarding cardiovascular events in patients implanted with a cardiac resynchronization therapy device. The secondary objective was to evaluate whether SonR™ signal evolution was associated with cardiovascular death. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.07.003DOI Listing
January 2019
2 Reads

Transoesophageal echocardiography current practice in France: A multicentre study.

Arch Cardiovasc Dis 2018 Dec 4;111(12):730-738. Epub 2018 Jul 4.

Department of cardiology, SOS Endocardites, Henri-Mondor Hospital, 94010 Creteil, France.

Background: Few data are available on the application of transoesophageal echocardiography (TOE) recommendations in daily practice.

Aims: To evaluate TOE practice based on echocardiography societies' guidelines, and to determine complication rates and factors associated with patient feelings.

Methods: Between April and June 2017, we prospectively included all consecutive patients referred to 14 French hospitals for a transoesophageal echocardiogram (TOE). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.03.014DOI Listing
December 2018
4 Reads

Evaluation of left ventricular filling pressure: Updated recommendations lack new evidence and have severe interpretation issues.

Arch Cardiovasc Dis 2018 Dec 23;111(12):707-711. Epub 2018 Nov 23.

Department of Cardiology, Université de Versailles-Saint Quentin (UVSQ), Ambroise-Paré Hospital, Centre de Référence des Maladies Cardiaques Héréditaires, AP-HP, 92100 Boulogne-Billancourt, France; Inserm U1018, CESP, Team 5 (EpReC: Renal and Cardiovascular Epidemiology), UVSQ, 94807 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.09.002DOI Listing
December 2018
1 Read

Initial forensic evaluation of Takotsubo syndrome and its causal relationship to a traumatic event.

Arch Cardiovasc Dis 2018 Dec 12;111(12):703-706. Epub 2018 Nov 12.

Service de médecine légale, hôpital Trousseau, avenue de la République, 37170 Chambray-Lès-Tours, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183016
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.09.001DOI Listing
December 2018
10 Reads

The best in coronary artery disease management is yet to come.

Arch Cardiovasc Dis 2018 Nov 23;111(11):621-624. Epub 2018 Oct 23.

Service de pharmacologie médicale, hôpital Bretonneau, CHRU de Tours & EA7501-GICC, université de Tours, 37000 Tours, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183014
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.10.001DOI Listing
November 2018
22 Reads

Renal denervation in hypertension: Towards a true revival?

Arch Cardiovasc Dis 2018 Oct 12;111(10):541-544. Epub 2018 Sep 12.

Cardiology Department, European Society of Hypertension Excellence Centre, hôpital de la Croix-Rousse et hôpital Lyon Sud, hospices civils de Lyon, 69004 Lyon, France; CREATIS, CNRS UMR 5220, INSERM U1044, INSA-Lyon, université Claude-Bernard Lyon 1, hospices civils de Lyon, 69100 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.08.001DOI Listing
October 2018
4 Reads

Vasospastic angina: A literature review of current evidence.

Arch Cardiovasc Dis 2019 Jan 7;112(1):44-55. Epub 2018 Sep 7.

Cardiology department, hôpital Cochin, AP-HP, 75014 Paris, France; Faculté de médecine, université Paris Descartes, 75006 Paris, France.

Vasospastic angina (VSA) is a variant form of angina pectoris, in which angina occurs at rest, with transient electrocardiogram modifications and preserved exercise capacity. VSA can be involved in many clinical scenarios, such as stable angina, sudden cardiac death, acute coronary syndrome, arrhythmia or syncope. Coronary vasospasm is a heterogeneous phenomenon that can occur in patients with or without coronary atherosclerosis, can be focal or diffuse, and can affect epicardial or microvasculature coronary arteries. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183013
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.08.002DOI Listing
January 2019
27 Reads

Left superior vena cava draining into the left atrium: Clinical entities, diagnosis and surgical treatment.

Arch Cardiovasc Dis 2019 Feb 1;112(2):135-143. Epub 2018 Sep 1.

Biosanitary Research Institute of Granada (ibs.GRANADA), 18012 Granada, Spain; Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, 18014 Granada, Spain; Department of Surgery and its Specialities, University of Granada, 18016 Granada, Spain. Electronic address:

Left superior vena cava draining into the left atrium in the absence of coronary sinus is an anomaly that can appear in heterotaxy syndrome and unroofed coronary sinus syndrome. Regardless of the origin of these syndromes, biventricular repair can be done through rerouting by intracardiac procedures or through disconnection-reconnection of the left superior vena cava to the right atrium or right superior vena cava by extracardiac procedures. Different techniques can be used for this purpose, each of which has its own advantages and limitations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.05.007DOI Listing
February 2019
10 Reads

Position paper concerning the competence, performance and environment required in the practice of complex ablation procedures.

Arch Cardiovasc Dis 2019 Jan 27;112(1):67-73. Epub 2018 Aug 27.

University Hospital of Nancy, 54511 Vandoeuvre-lès-Nancy, France.

The introduction of catheter ablation techniques has vastly improved the treatment of cardiac arrhythmias. However, as complex ablations are technically demanding and can cause various complications, they require a high level of expertise to maximize success rates and minimize complication rates. As French recommendations regarding the required technical competence and equipment are not yet available, this position paper has been compiled by the Working Group of Pacing and Electrophysiology of the French Society of Cardiology, detailing the required features of an interventional cardiac electrophysiological centre for complex ablation procedures: (1) sufficient institutional volume; (2) physician training, qualifications and experience; (3) paramedical staff training and attendance; and (4) institutional facilities and technical equipment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.05.006DOI Listing
January 2019
6 Reads

French Society of Cardiology guidelines on exercise tests (part 2): Indications for exercise tests in cardiac diseases.

Arch Cardiovasc Dis 2019 Jan 6;112(1):56-66. Epub 2018 Aug 6.

Department of Sport Medicine, Pontchaillou Hospital, University of Rennes 1, Inserm 1099, 35043 Rennes, France.

The exercise test is performed routinely in cardiology; its main indication is the diagnosis of myocardial ischemia, evaluated along with the subject's pretest probability and cardiovascular risk level. Other criteria, such as analysis of repolarization, must be taken into consideration during the interpretation of an exercise test, to improve its predictive value. An exercise test is also indicated for many other cardiac diseases (e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.07.001DOI Listing
January 2019
8 Reads

French Society of Cardiology guidelines on exercise tests (part 1): Methods and interpretation.

Arch Cardiovasc Dis 2018 Dec 6;111(12):782-790. Epub 2018 Aug 6.

Department of Sport Medicine, Pontchaillou Hospital, Inserm 1099, University of Rennes 1, 35043 Rennes, France.

The exercise test is still a key examination in cardiology, used for the diagnosis of myocardial ischemia, as well as for the clinical evaluation of other heart diseases. The cardiopulmonary exercise test can further define functional capacity and prognosis for any given cardiac pathology. These new guidelines focus on methods, interpretation and indications for an exercise test or cardiopulmonary exercise test, as summarized below. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18752136183010
Publisher Site
http://dx.doi.org/10.1016/j.acvd.2018.05.005DOI Listing
December 2018
14 Reads

Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.

Arch Cardiovasc Dis 2018 Dec 2;111(12):758-765. Epub 2018 Aug 2.

Paris Descartes University, 75006 Paris, France.

Background: The frequency, characteristics and outcomes of primary prevention implantable cardioverter defibrillator (ICD) recipients who eventually undergo heart transplantation (HT) during follow-up have not been well described.

Aims: In a cohort of patients with heart failure implanted with an ICD for primary prevention of sudden cardiac death, to identify those at high risk of subsequent HT and evaluate ICD usefulness.

Methods: Between 2002 and 2012, 5539 patients received a primary prevention ICD across 12 centers, and were enrolled in the DAI-PP programme, including 5427 with full HT information available. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2018.05.004DOI Listing
December 2018
13 Reads